Who we are

We are a team with extensive experience in drug development from the pharmaceutical industry, focusing on discovery and development of novel immunotherapeutic products. .

What we do

We design and develop new organ-restricted chemical entities that addresses unmet medical needs in cancer and fibrosis.

read more
pharmaceutic

Innovative Small Molecules

Our focus is to create novel chemical entities that modulates the immune system .

Organ Restrictive Compounds

Our aim is the development of organ-restricted compounds to maximize the benefit/risk ratio

Well Validated Targets

Our target is the treatment of cancer and fibrosis through immunomodulation therapy by TGF-β inhibition

Our mission

The discovery and development of next generation therapeutic products for treatment of severe diseases linked to TGF-β.

Our vision

To improve life quality and ultimately, contribute to the curing of people suffering from devastating medical conditions.